Lipomatous hypertrophy of the interatrial septum (LHIS) is a benign anomaly with low prevalence. Lipomatous hypertrophy of the interatrial septum is asymptomatic in most of the cases and rarely leads to atrial arrhythmias, obstructive flow symptoms, or sudden death. It is mostly diagnosed as an incidental finding in cross-sectional imaging and echocardiography, and increased 18F-FDG uptake on LHIS has been described. We present a case of repeated increased 18F-PSMA uptake in LHIS. Although very rare, familiarity with the typical features and prevalence of LHIS in PET/CT can avoid misinterpretation for metastatic disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLU.0000000000004551 | DOI Listing |
Mayo Clin Proc
December 2024
Department of Laboratory Medicine and Pathology and Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Cureus
October 2024
Department of Anatomical Sciences, William Carey University College of Osteopathic Medicine, Hattiesburg, USA.
Cureus
October 2024
Interventional Cardiology, Vila Nova de Gaia/Espinho Hospital Center, Vila Nova de Gaia, PRT.
Platypnea-orthodeoxia syndrome (POS) is characterized by dyspnea due to a marked fall in blood oxygen saturation while assuming standing or sitting positions. It is a rare condition with an unknown prevalence. The triggering role may remain unclear in a considerable number of patients.
View Article and Find Full Text PDFERJ Open Res
September 2024
Department of Radiology, Innsbruck Medical University, Innsbruck, Austria.
Objective: Lipomatous hypertrophy of the interatrial septum (LHIS) is a distinct section of epicardial adipose tissue. However, its association with COPD is poorly documented.
Methods: Patients undergoing coronary computed tomography angiography (CTA) for clinical indications were recruited retrospectively and screened for LHIS and COPD.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!